Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b58f981963f6d55d627139e778c4ef7b |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-133 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
filingDate |
2009-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08e34bd1d3c9476ecfac1c5d1e6dc55b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55f191c258aea95f368a01e17d016806 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd163c7ec2d955eef297846dad7bf56c |
publicationDate |
2010-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
TN-2009000159-A1 |
titleOfInvention |
DMAE AS A UNIQUE AGENT FOR THE TREATMENT OF LIGHT COGNITIVE DEFICIT |
abstract |
The present invention relates to the use as sole active ingredient dimethylaminoethanol (DMAE) in free form, salts or esters and their hydrates and solvates, for the manufacture of a drug for the treatment of a deficit light non-dementia cognitive characterized by amnesic syndrome of hippocampal type. |
priorityDate |
2006-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |